These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 10819124)
21. Double-blind placebo-controlled trial of secretin: effects on aberrant behavior in children with autism. Carey T; Ratliff-Schaub K; Funk J; Weinle C; Myers M; Jenks J J Autism Dev Disord; 2002 Jun; 32(3):161-7. PubMed ID: 12108617 [TBL] [Abstract][Full Text] [Related]
22. A double-blind, placebo-controlled crossover study investigating the effect of porcine secretin in children with autism. Corbett B; Khan K; Czapansky-Beilman D; Brady N; Dropik P; Goldman DZ; Delaney K; Sharp H; Mueller I; Shapiro E; Ziegler R Clin Pediatr (Phila); 2001 Jun; 40(6):327-31. PubMed ID: 11824175 [TBL] [Abstract][Full Text] [Related]
23. Secretin is an ineffective treatment for pervasive developmental disabilities: a review of 15 double-blind randomized controlled trials. Sturmey P Res Dev Disabil; 2005; 26(1):87-97. PubMed ID: 15590241 [TBL] [Abstract][Full Text] [Related]
24. Administration of secretin for autism alters dopamine metabolism in the central nervous system. Toda Y; Mori K; Hashimoto T; Miyazaki M; Nozaki S; Watanabe Y; Kuroda Y; Kagami S Brain Dev; 2006 Mar; 28(2):99-103. PubMed ID: 16168596 [TBL] [Abstract][Full Text] [Related]
26. Collaborative approach to autism: a parent's perspective. Quirantes D J Spec Pediatr Nurs; 2009 Jul; 14(3):203-5. PubMed ID: 19614830 [TBL] [Abstract][Full Text] [Related]
27. Novel treatments for autistic spectrum disorders. Levy SE; Hyman SL Ment Retard Dev Disabil Res Rev; 2005; 11(2):131-42. PubMed ID: 15977319 [TBL] [Abstract][Full Text] [Related]
28. A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism. Coniglio SJ; Lewis JD; Lang C; Burns TG; Subhani-Siddique R; Weintraub A; Schub H; Holden EW J Pediatr; 2001 May; 138(5):649-55. PubMed ID: 11343038 [TBL] [Abstract][Full Text] [Related]
29. Secretin for the treatment of autism. McQueen JM; Heck AM Ann Pharmacother; 2002 Feb; 36(2):305-11. PubMed ID: 11847953 [TBL] [Abstract][Full Text] [Related]
30. Secretin and autism: a two-part clinical investigation. Chez MG; Buchanan CP; Bagan BT; Hammer MS; McCarthy KS; Ovrutskaya I; Nowinski CV; Cohen ZS J Autism Dev Disord; 2000 Apr; 30(2):87-94. PubMed ID: 10832772 [TBL] [Abstract][Full Text] [Related]
31. Children with autistic spectrum disorders. II: parents are unable to distinguish secretin from placebo under double-blind conditions. Coplan J; Souders MC; Mulberg AE; Belchic JK; Wray J; Jawad AF; Gallagher PR; Mitchell R; Gerdes M; Levy SE Arch Dis Child; 2003 Aug; 88(8):737-9. PubMed ID: 12876178 [TBL] [Abstract][Full Text] [Related]
32. "Lessons learned from autism: a parent's perspective". Smith LM Curr Probl Pediatr Adolesc Health Care; 2011 Apr; 41(4):117-8. PubMed ID: 21440231 [No Abstract] [Full Text] [Related]
36. The effectiveness of secretin in the management of autism. Kern JK; Espinoza E; Trivedi MH Expert Opin Pharmacother; 2004 Feb; 5(2):379-87. PubMed ID: 14996634 [TBL] [Abstract][Full Text] [Related]
37. Child care problems and employment among families with preschool-aged children with autism in the United States. Montes G; Halterman JS Pediatrics; 2008 Jul; 122(1):e202-8. PubMed ID: 18595965 [TBL] [Abstract][Full Text] [Related]